Cafepharma Today

Memorial Day Weekend 2025
We wish all our US visitors a safe and enjoyable holiday weekend. We remember those who have given their lives to defend and protect our country.

CP Today will resume on Tuesday, May 27

*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

FDA’s lab-developed test rule could be first test of agency’s power post-Chevron
BioPharma Dive
Sunday, July 14, 2024 - 10:16pm
tags:
FDA, lab-developed tests, diagnostics, Medtech, Supreme Court, Chevron Doctrine
Amgen’s Imdelltra BiTEs into SCLC treatment drought
Clinical Trials Arena
Sunday, July 14, 2024 - 10:15pm
tags:
Amgen, Imdelltra, small cell lung cancer, BiTEs
AbbVie Submits Applications for Rinvoq for Giant Cell Arteritis
Managed Healthcare Executive
Sunday, July 14, 2024 - 10:12pm
tags:
AbbVie, Rinvoq, FDA, EMA, giant cell arteritis
AbbVie’s Humira continues to lose market share as biosimilars gain ground
BioSpace
Friday, July 12, 2024 - 11:35am
tags:
AbbVie, Humira, biosimilars
Move over, oncology: Obesity, diabetes meds will take over 2030's top drug rankings, Evaluate forecasts
Fierce Pharma
Friday, July 12, 2024 - 11:33am
tags:
obesity, diabetes, oncology, Novo Nordisk, Eli Lilly
FTC poised to sue drug middlemen over insulin prices
Axios
Friday, July 12, 2024 - 11:30am
tags:
FTC, PBMs, insulin, diabetes, drug pricing, legal, CVS Caremark, Express Scripts, OptumRx
Leqembi sales inch higher; Spark’s pivot leads to layoffs
BioPharma Dive
Friday, July 12, 2024 - 11:29am
tags:
Eisai, Biogen, Leqembi, Alzheimer's disease, Roche, Spark Therapeutics, gene therapy, layoffs
Novo Nordisk's Ozempic cuts dementia risk compared with Merck's Januvia: Oxford study
Fierce Pharma
Friday, July 12, 2024 - 11:28am
tags:
Novo Nordisk, Ozempic, dementia, Merck, Januvia
Immutep Aces Phase IIb in First-Line Head and Neck Cancer, Eyes Regulatory Path Ahead
BioSpace
Friday, July 12, 2024 - 11:26am
tags:
IMMUTEP, head and neck cancer, eftilagimod alfa, clinical trials
Patients on weight-loss drugs should inform doctor before surgery, EU regulator says
Reuters
Friday, July 12, 2024 - 11:16am
tags:
EMA, Novo Nordisk, Ozempic, Wegovy, Eli Lilly, Mounjaro, Zepbound, surgery
Pfizer's obesity pill news leaves analysts wanting, biotech investors cheering
Fierce Biotech
Friday, July 12, 2024 - 11:14am
tags:
Pfizer, obesity, danuglipron, Viking Therapeutics, Terns Pharmaceuticals
Leqembi gains approval for Alzheimer’s treatment in Israel
Pharmaceutical Business Review
Friday, July 12, 2024 - 11:12am
tags:
Eisai, Israel, Alzheimer's disease, Leqembi, BioArctic
BMS’ long-standing leukemia blockbuster stares down its first generic
Pharma Voice
Friday, July 12, 2024 - 11:10am
tags:
Bristol Myers Squibb, Sprycel, leukemia, generics, CML, Xspray Pharma
Vivani to start in-human trial for GLP-1 implant for treating obesity
Clinical Trials Arena
Friday, July 12, 2024 - 11:08am
tags:
Vivani Medical, clinical trials, GLP-1 implant, obesity
Biotech investors remain cautious in a stabilizing funding environment
Clinical Trials Arena
Thursday, July 11, 2024 - 11:03pm
tags:
biotech, funding, clinical trials
AbbVie asks Supreme Court to uphold attorney-client privilege in AndroGel lawsuit
Fierce Pharma
Thursday, July 11, 2024 - 11:02pm
tags:
AbbVie, Androgel, legal, Supreme Court, generics
Unpacking the PREVAIL Act: What pharma marketers need to know
Medical Marketing and Media
Thursday, July 11, 2024 - 10:59pm
tags:
legislation, patents, PREVAIL
Element Biosciences nets $277M ahead of new sequencer launch
Fierce Biotech
Thursday, July 11, 2024 - 10:57pm
tags:
Element Biosciences, funding, venture capital, DNA sequencing, Illumina, Medtech
AskBio receives FDA Fast Track and MHRA Innovation Passport Designations for AB-1005 Investigational GDNF Gene Therapy for Parkinson’s Disease
Drugs.com
Thursday, July 11, 2024 - 10:55pm
tags:
Bayer, AskBio, FDA, AB-1005, Parkinson's Disease, fast track status
FDA details how pharma companies can counter health misinformation
Medical Marketing and Media
Thursday, July 11, 2024 - 10:52pm
tags:
FDA, misinformation, social media

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.